‘Don’t freak out’: Vaccine bosses attempt to diffuse Omicron-induced jab fears November 30, 2021 Vaccine leaders have rushed to put out the fires of Moderna CEO’s jab cautions, urging the world: “Don’t freak out”. Pharmaceutical heavyweights have been gathering data on the latest Covid-19 variant Omicron, as concerns swell that a tailor-made vaccine may be necessary. AstraZeneca is already researching locations where the variant has been identified, namely in [...]
AstraZeneca opens new £1bn research fortress in Cambridge for army of 2,200 scientists November 25, 2021 AstraZeneca has officially opened The Discovery Centre (DISC) in Cambridge, its newest research and development facility which will swing open its doors to 2,200 research scientists from today. The new £1bn facility will include robotics, high-throughput screening and AI-driven technology. It will support AstraZeneca’s focus on specialised and precision medicines and foster the discovery and [...]
Covid-19 global pandemic to be ‘regional epidemic’ by next year, says AstraZeneca boss November 23, 2021 AstraZeneca boss Pascal Soriot said that he expects the global Covid-19 pandemic to become a regional epidemic by next year, after the pharmaceutical giant decided to start profiting from its vaccine. The chief executive of the pharmaceutical giant told Sky News that by 2022, “essentially most of the world at that point will be in [...]
AstraZeneca sales jump 50 per cent as vaccine crawls to profitability November 12, 2021 AstraZeneca’s revenues have soared 32 per cent this year to $25.4bn, powered by booming product sales. Third quarter revenues are up 50 per cent, with the pharmaceutical giant enjoying a $9.87 billion increase in revenues over the three-month period. The company has sold 2.2 billion vaccines since the start of the year. It has now [...]
AstraZeneca says new Coronavirus antibody treatment can prevent as well as cure Covid-19 October 11, 2021 AstraZeneca said in a filing this morning that a new antibody treatment the British pharma giant has developed has the ability to prevent as well as treat Covid-19. The company has filed a request to the US Food and Drug Administration (FDA) last week for emergency use authorisation for AZD7442, which is made up of [...]
Oxford-AstraZeneca vaccine creator to make keynote speech at UK’s Global Investment Summit October 11, 2021 The UK’s pharmaceutical industry is set to take top billing at the UK’s Global Investment Summit next week, with GlaxoSmithKline’s chief executive and one of the creator’s of the Oxford-AstraZeneca vaccine to deliver keynote speeches. GSK chief Dame Emma Walmsley and Oxford University vaccinologist Sarah Gilbert will be alongside World Trade Organisation (WTO) director-general Dr [...]
Your third Covid shot is coming: All you need to know about booster vaccines October 3, 2021 It seems inevitable: a third Covid shot is coming your way this Autumn. Two jabs may not give us sufficient protection, or at least not in the long term. Booster jabs are being offered as part of a ramped-up vaccine campaign in England. Some 1.5 million people will be contacted and encouraged to use the [...]
EU vs Astrazeneca: Vaccine legal battle over as UK pharma pledges jab deliveries September 3, 2021 The legal stand-off between the European Union (EU) and FTSE-listed Covid-19 vaccine maker Astrazeneca appears to be over. Astrazeneca and the European Commission have reached a settlement on the delivery of 200m vaccine doses still to be delivered by the drug com[any, ending a row about shortages that had heightened reputational damage on Astra and weighed [...]
Fatal blood clot: Coroner rules AstraZeneca vaccine caused death of BBC host Lisa Shaw August 27, 2021 The death of award-winning BBC radio presenter Lisa Shaw was caused by complications as a result of the AstraZeneca Covid-19 vaccine, a coroner in Newcastle has concluded. Shaw died in May, just over three weeks after she had her first dose of the jab, an inquest in Newcastle heard on Thursday. The 44-year-old – who [...]
Astrazeneca’s non-vaccine therapy cuts chance of getting symptomatic Covid by 77 per cent, trial finds August 20, 2021 FTSE-listed Astrazeneca this morning said its Covid-19 antibody therapy met the main goal of preventing coronavirus symptoms in a late-stage study. It means the Anglo-Swedish pharma is on track to potentially offer an alternative to vaccines for people with weakened immune systems. Astrazeneca said it will now submit data to try and get emergency authorisation [...]